Year archive

Nykode Therapeutics ASA — 2021 filings

All 101 regulatory filings released by Nykode Therapeutics ASA (NYKD) in 2021, sourced directly from the official regulator.

101 Filings

2021 Period

2021 filings (101)

Filing	Released	Lang
Financial calendar Report Publication Announcement	2021-12-30	English
Nykode Therapeutics announces first subject dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate Regulatory Filings	2021-12-28	English
Nykode Therapeutics announces first subject dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate Regulatory Filings	2021-12-28	English
Minutes of Extraordinary General Meeting AGM Information	2021-12-22	English
Minutes of Extraordinary General Meeting AGM Information	2021-12-22	English
Nykode Therapeutics AS - Mandatory notification of purchase by related party to primary insider Director's Dealing	2021-12-20	English
Nykode Therapeutics AS - Mandatory notification of purchase by related party to primary insider Director's Dealing	2021-12-20	English
Share capital increase from exercise of warrants Share Issue/Capital Change	2021-12-20	English
Nykode Therapeutics AS - New name registered Regulatory Filings	2021-12-15	Norwegian
Vaccibody AS*) – Notice of Extraordinary General Meeting AGM Information	2021-12-15	Norwegian
Vaccibody AS*) – Notice of Extraordinary General Meeting AGM Information	2021-12-15	English
Vaccibody AS*) – Notice of Extraordinary General Meeting AGM Information	2021-12-15	English
Vaccibody AS*) – Notice of Extraordinary General Meeting AGM Information	2021-12-15	English
New chairman at Nykode Therapeutics as the Company enters a new stage of internationalization Board/Management Information	2021-12-15	English
New chairman at Nykode Therapeutics as the Company enters a new stage of internationalization Board/Management Information	2021-12-15	English
Registration of new share capital Share Issue/Capital Change	2021-12-09	English
Mandatory notification of trade by primary insiders and related parties Director's Dealing	2021-12-03	English
Mandatory notification of trade by primary insiders and related parties Director's Dealing	2021-12-03	English
Subscription of warrants Director's Dealing	2021-12-03	English
Subscription of warrants Share Issue/Capital Change	2021-12-03	English
Minutes of Extraordinary General Meeting AGM Information	2021-11-30	English
Minutes of Extraordinary General Meeting AGM Information	2021-11-30	English
Nykode Therapeutics (formerly Vaccibody*)) resolves to issue shares to Regeneron Share Issue/Capital Change	2021-11-24	English
Nykode Therapeutics (formerly Vaccibody*)) enters into multi-target license and collaboration agreement with Regeneron to develop innovative vaccines against cancer and infectious diseases Regulatory Filings	2021-11-23	English
Nykode Therapeutics (formerly Vaccibody*)) enters into multi-target license and collaboration agreement with Regeneron to develop innovative vaccines against cancer and infectious diseases Capital/Financing Update	2021-11-23	English
Vaccibody AS – Notice of Extraordinary General Meeting AGM Information	2021-11-23	Norwegian
Vaccibody AS – Notice of Extraordinary General Meeting AGM Information	2021-11-23	Norwegian
Vaccibody AS – Notice of Extraordinary General Meeting AGM Information	2021-11-23	English
Vaccibody AS – Notice of Extraordinary General Meeting AGM Information	2021-11-23	English
Vaccibody becomes Nykode Therapeutics - a new name and identity to signify a new phase of growth and development Regulatory Filings	2021-11-23	English
Vaccibody becomes Nykode Therapeutics - a new name and identity to signify a new phase of growth and development Regulatory Filings	2021-11-23	English
Vaccibody AS - Quarterly report Q3 2021 Interim / Quarterly Report Q3 2021	2021-11-17	English
Vaccibody AS - Quarterly report Q3 2021 Report Publication Announcement	2021-11-17	English
Vaccibody to participate at Jefferies London Healthcare Conference Regulatory Filings	2021-11-10	English
Vaccibody to participate at Jefferies London Healthcare Conference Regulatory Filings	2021-11-10	English
Vaccibody announces first subject dosed in a two-arm phase 1/2 clinical trial with next-generation SARS-CoV-2 vaccine candidates Regulatory Filings	2021-11-03	English
Vaccibody announces first subject dosed in a two-arm phase 1/2 clinical trial with next-generation SARS-CoV-2 vaccine candidates Earnings Release Q4 2021	2021-11-03	English
Mandatory notification of intra group transfer of shares by primary insider’s related party Director's Dealing	2021-11-02	English
Mandatory notification of intra group transfer of shares by primary insider’s related party Director's Dealing	2021-11-02	English
Registration of new share capital Share Issue/Capital Change	2021-11-01	English
Share capital increase from exercise of warrants Share Issue/Capital Change	2021-10-29	English
Mandatory notification of intra group transfer of shares by primary insider’s related party Director's Dealing	2021-10-14	English
Mandatory notification of intra group transfer of shares by primary insider’s related party Director's Dealing	2021-10-14	English
Mandatory notification of intra group transfer of shares by primary insider’s related party Director's Dealing	2021-10-12	English
Mandatory notification of intra group transfer of shares by primary insider’s related party Director's Dealing	2021-10-12	English
Vaccibody to participate at Guggenheim Securities’ 2nd Annual Vaccine and Infectious Disease Days Report Publication Announcement	2021-10-04	English
Vaccibody to participate at Guggenheim Securities’ 2nd Annual Vaccine and Infectious Disease Days Regulatory Filings	2021-10-04	English
Resolution to issue shares as a consequence of option exercise Share Issue/Capital Change	2021-09-30	English
Mandatory notification of transfer of shares by primary insider to closely associated person Director's Dealing	2021-09-24	English
Mandatory notification of transfer of shares by primary insider to closely associated person Director's Dealing	2021-09-24	English
Vaccibody AS - Mandatory notification of intra group transfer of shares by primary insider’s related party Director's Dealing	2021-09-20	English
Vaccibody AS - Mandatory notification of intra group transfer of shares by primary insider’s related party Director's Dealing	2021-09-20	English
Vaccibody AS - Mandatory notification of intra group transfer of shares by primary insider’s related party Director's Dealing	2021-09-20	English
Vaccibody AS - Mandatory notification of intra group transfer of shares by primary insider’s related party Director's Dealing	2021-09-10	English
Vaccibody AS - Mandatory notification of intra group transfer of shares by primary insider’s related party Director's Dealing	2021-09-10	English
Share capital increase from exercise of warrants Share Issue/Capital Change	2021-09-07	English
Vaccibody AS - Quarterly report Q2 2021 Interim / Quarterly Report Q2 2021	2021-08-26	English
Vaccibody AS - Quarterly report Q2 2021 Report Publication Announcement	2021-08-26	English
Vaccibody Q2 and half-year report 2021 webcast Report Publication Announcement	2021-08-23	English
Vaccibody Q2 and half-year report 2021 webcast Report Publication Announcement	2021-08-23	English
Share capital increase from exercise of warrants Share Issue/Capital Change	2021-06-29	English
Vaccibody to initiate a phase 1/2 trial to evaluate two second-generation SARS CoV-2 virus DNA vaccine candidates to address emerging variants of concern Regulatory Filings	2021-06-29	English
Vaccibody to initiate a phase 1/2 trial to evaluate two second-generation SARS CoV-2 virus DNA vaccine candidates to address emerging variants of concern Investor Presentation	2021-06-29	English
Grant of Share Options Director's Dealing	2021-06-14	English
Grant of Share Options Share Issue/Capital Change	2021-06-14	English
Vaccibody to present at Goldman Sachs 42nd Annual Global Healthcare Conference Regulatory Filings	2021-06-09	English
Vaccibody to present at Goldman Sachs 42nd Annual Global Healthcare Conference Regulatory Filings	2021-06-09	English
Grant of Restricted Share Units and Share Options Remuneration Information	2021-06-03	English
Grant of Restricted Share Units and Share Options Remuneration Information	2021-06-03	English
Vaccibody to present at Jefferies Virtual Healthcare Conference (June 1-4, 2021) Regulatory Filings	2021-05-31	English
Vaccibody to present at Jefferies Virtual Healthcare Conference (June 1-4, 2021) Regulatory Filings	2021-05-31	English
Share capital increase from exercise of warrants Share Issue/Capital Change	2021-05-12	English
Vaccibody AS - Quarterly report Q1 2021 Interim / Quarterly Report Q1 2021	2021-05-12	English
Vaccibody AS - Quarterly report Q1 2021 Report Publication Announcement	2021-05-12	English
Vaccibody appoints Mikkel Wandahl Pedersen as new Chief Scientific Officer and Agnete B. Fredriksen as Chief Innovation & Strategy Officer Board/Management Information	2021-05-12	English
Vaccibody appoints Mikkel Wandahl Pedersen as new Chief Scientific Officer and Agnete B. Fredriksen as Chief Innovation & Strategy Officer Board/Management Information	2021-05-12	English
Mandatory notification of exercise of warrants Director's Dealing	2021-05-07	English
Mandatory notification of exercise of warrants Share Issue/Capital Change	2021-05-07	English
Vaccibody AS appoints Dr. Volck, M.D., Ph.D. as new member of the Board Board/Management Information	2021-05-05	English
Vaccibody AS appoints Dr. Volck, M.D., Ph.D. as new member of the Board Board/Management Information	2021-05-05	English
Minutes of the Annual General Meeting AGM Information	2021-05-05	English
Minutes of the Annual General Meeting AGM Information	2021-05-05	English
Grant of share options Remuneration Information	2021-05-04	English
Grant of share options Share Issue/Capital Change	2021-05-04	English
Status update on VB C-02 clinical trial with VB10.16 and immune checkpoint inhibitor atezolizumab in patients with advanced cervical cancer Investor Presentation	2021-04-30	English
Status update on VB C-02 clinical trial with VB10.16 and immune checkpoint inhibitor atezolizumab in patients with advanced cervical cancer Regulatory Filings	2021-04-30	English
Vaccibody AS - Notice of Annual General Meeting on 5 May 2021 AGM Information	2021-04-28	English
Vaccibody AS - Notice of Annual General Meeting on 5 May 2021 AGM Information	2021-04-28	English
Vaccibody AS - Notice of Annual General Meeting on 5 May 2021 Annual Report FY 2020	2021-04-28	English
Vaccibody appoints Harald Gurvin as new Chief Financial Officer Board/Management Information	2021-04-28	English
Mandatory notification of trade - party related to primary insider Director's Dealing	2021-04-22	English
Vaccibody AS - Annual Report 2020 Annual Report FY 2020	2021-04-21	English
Vaccibody AS - Annual Report 2020 Report Publication Announcement	2021-04-21	English
Share capital increase from exercise of warrants Share Issue/Capital Change	2021-03-17	English
Mandatory notification of exercise of warrants and acquisition of shares by primary insiders Director's Dealing	2021-03-08	English
Vaccibody to adopt IFRS (International Financial Reporting Standards) and to explore a potential listing of its shares on the Nasdaq Global Market in the United States Report Publication Announcement	2021-03-05	English
Vaccibody to adopt IFRS (International Financial Reporting Standards) and to explore a potential listing of its shares on the Nasdaq Global Market in the United States Capital/Financing Update	2021-03-05	English
Financial calendar Report Publication Announcement	2021-02-17	English
Vaccibody will recruit new CFO Board/Management Information	2021-02-05	English
Vaccibody will recruit new CFO Board/Management Information	2021-02-05	English
Financial calendar Report Publication Announcement	2021-01-27	English